P19-02. High protection of female macaques from repeated intravaginal challenges with SHIV-162P3 upon mucosal vaccination with Gp41 subunits-virosomes

Benzer Materyaller

• Randomized Phase I: Safety, Immunogenicity and Mucosal Antiviral Activity in Young Healthy Women Vaccinated with HIV-1 Gp41 P1 Peptide on Virosomes.
  Yazar:: Geert Leroux-Roels, ve diğerleri
  Baskı/Yayın Bilgisi: (2013-01-01)
• Randomized Phase I: Safety, Immunogenicity and Mucosal Antiviral Activity in Young Healthy Women Vaccinated with HIV-1 Gp41 P1 Peptide on Virosomes
  Yazar:: Leroux-Roels, Geert, ve diğerleri
  Baskı/Yayın Bilgisi: (2013)
• Virus-specific T cell responses in macaques acutely infected with SHIV(sf162p3)
  Yazar:: Pahar, Bapi, ve diğerleri
  Baskı/Yayın Bilgisi: (2007)
• Differential Pathogenicity of SHIV(SF162 P4) Infection in Pig-tailed and Rhesus Macaques
  Yazar:: Polacino, Patricia, ve diğerleri
  Baskı/Yayın Bilgisi: (2008)
• An Intravaginal Ring That Releases the NNRTI MIV-150 Reduces SHIV Transmission in Macaques
  Yazar:: Singer, Rachel, ve diğerleri
  Baskı/Yayın Bilgisi: (2012)